TY  - GEN
AU  - Druker,Brian J
TI  - Taking aim at Ewing's sarcoma: is KIT a target and will imatinib work?
SN  - 0027-8874
PY  - 2002///1211
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Benzamides
KW  - Bone Neoplasms
KW  - drug therapy
KW  - Clinical Trials, Phase I as Topic
KW  - Dose-Response Relationship, Drug
KW  - Enzyme Inhibitors
KW  - Humans
KW  - Imatinib Mesylate
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - Piperazines
KW  - Protein-Tyrosine Kinases
KW  - antagonists & inhibitors
KW  - Proto-Oncogene Proteins c-kit
KW  - drug effects
KW  - Pyrimidines
KW  - Sarcoma, Ewing
KW  - Treatment Outcome
KW  - Tumor Cells, Cultured
N1  - Publication Type: Comment; Editorial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1093/jnci/94.22.1660
ER  -